vs
Side-by-side financial comparison of Great Elm Group, Inc. (GEG) and Instil Bio, Inc. (TIL). Click either name above to swap in a different company.
Great Elm Group, Inc. is the larger business by last-quarter revenue ($3.0M vs $2.2M, roughly 1.3× Instil Bio, Inc.). Instil Bio, Inc. runs the higher net margin — -365.3% vs -549.6%, a 184.2% gap on every dollar of revenue. On growth, Great Elm Group, Inc. posted the faster year-over-year revenue change (-14.1% vs -19.2%).
Great Elm Group, Inc. is an alternative asset management firm that offers private credit products, real asset investment vehicles, and customized capital solutions for small and medium-sized enterprises. It primarily serves institutional investors and high-net-worth individuals across the North American market.
Instil Bio Inc. is a clinical-stage biotechnology company focused on developing innovative tumor-infiltrating lymphocyte (TIL) therapies for patients with difficult-to-treat advanced solid tumors. It operates in the immuno-oncology segment, serving patient populations that show limited response to existing standard cancer treatment options.
GEG vs TIL — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $3.0M | $2.2M |
| Net Profit | $-16.5M | $-8.2M |
| Gross Margin | 99.5% | — |
| Operating Margin | -140.6% | -426.3% |
| Net Margin | -549.6% | -365.3% |
| Revenue YoY | -14.1% | -19.2% |
| Net Profit YoY | -1507.1% | 31.1% |
| EPS (diluted) | $-0.50 | $-1.13 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $3.0M | $2.2M | ||
| Q3 25 | $10.8M | $2.2M | ||
| Q2 25 | — | $2.2M | ||
| Q1 25 | $3.2M | $2.2M | ||
| Q4 24 | $3.5M | $2.8M | ||
| Q3 24 | $4.0M | $1.5M | ||
| Q2 24 | — | $0 | ||
| Q1 24 | $2.8M | $0 |
| Q4 25 | $-16.5M | $-8.2M | ||
| Q3 25 | $-7.9M | $-13.6M | ||
| Q2 25 | — | $-21.4M | ||
| Q1 25 | $-4.5M | $-28.2M | ||
| Q4 24 | $1.2M | $-11.9M | ||
| Q3 24 | $2.6M | $-23.0M | ||
| Q2 24 | — | $-14.9M | ||
| Q1 24 | $-3.1M | $-24.3M |
| Q4 25 | 99.5% | — | ||
| Q3 25 | 37.4% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 86.9% | — | ||
| Q3 24 | 84.1% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -140.6% | -426.3% | ||
| Q3 25 | -34.5% | -670.0% | ||
| Q2 25 | — | -1045.5% | ||
| Q1 25 | -79.6% | -1363.2% | ||
| Q4 24 | -56.4% | -426.1% | ||
| Q3 24 | -50.0% | -1582.8% | ||
| Q2 24 | — | — | ||
| Q1 24 | -67.1% | — |
| Q4 25 | -549.6% | -365.3% | ||
| Q3 25 | -73.3% | -606.0% | ||
| Q2 25 | — | -954.2% | ||
| Q1 25 | -140.1% | -1257.8% | ||
| Q4 24 | 33.5% | -428.8% | ||
| Q3 24 | 66.1% | -1541.9% | ||
| Q2 24 | — | — | ||
| Q1 24 | -111.2% | — |
| Q4 25 | $-0.50 | $-1.13 | ||
| Q3 25 | $-0.24 | $-2.01 | ||
| Q2 25 | — | $-3.24 | ||
| Q1 25 | $-0.17 | $-4.32 | ||
| Q4 24 | $0.04 | $-1.82 | ||
| Q3 24 | $0.08 | $-3.54 | ||
| Q2 24 | — | $-2.29 | ||
| Q1 24 | $-0.10 | $-3.74 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $51.2M | $6.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $55.8M | $113.9M |
| Total Assets | $135.5M | $203.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $51.2M | $6.6M | ||
| Q3 25 | $53.5M | $5.8M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | $31.5M | $15.4M | ||
| Q4 24 | $44.3M | $8.8M | ||
| Q3 24 | $44.1M | $6.7M | ||
| Q2 24 | — | $6.8M | ||
| Q1 24 | $44.1M | $5.5M |
| Q4 25 | $55.8M | $113.9M | ||
| Q3 25 | $73.8M | $120.4M | ||
| Q2 25 | — | $131.7M | ||
| Q1 25 | $57.2M | $144.9M | ||
| Q4 24 | $62.3M | $169.4M | ||
| Q3 24 | $63.9M | $176.3M | ||
| Q2 24 | — | $195.0M | ||
| Q1 24 | $65.0M | $205.8M |
| Q4 25 | $135.5M | $203.5M | ||
| Q3 25 | $155.0M | $211.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | $137.2M | $237.4M | ||
| Q4 24 | $138.5M | $263.6M | ||
| Q3 24 | $137.3M | $272.6M | ||
| Q2 24 | — | $294.3M | ||
| Q1 24 | $148.4M | $306.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.9M | $-7.1M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | — | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.9M | $-7.1M | ||
| Q3 25 | $3.8M | $-10.6M | ||
| Q2 25 | — | $-14.8M | ||
| Q1 25 | $-1.3M | $-4.2M | ||
| Q4 24 | $-4.0M | $-10.6M | ||
| Q3 24 | $-5.8M | $-20.1M | ||
| Q2 24 | — | $-10.6M | ||
| Q1 24 | $1.4M | $-14.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.0% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -3.44× | — | ||
| Q3 24 | -2.19× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEG
| Management Service Base | $1.8M | 60% |
| Other | $1.2M | 40% |
TIL
Segment breakdown not available.
